Company initiatives, Investments, Press Release

Codexis sells Budapest lab to Intrexon

Synthetic biology company, Intrexon Corporation, has acquired state-of-the-art laboratory operations in Budapest, Hungary from biocatalysts developer Codexis, Inc. The acquisition will expand Intrexon’s strain and protein development capabilities, as well as strengthen fermentation process optimization and scale-up. Intrexon’s Industrial Products Division (IPD) will absorb the Budapest laboratory staff.

Intrexon’s IPD is positioned to develop biologically based solutions across sectors – Health, Food, Energy, Environment, and Consumer – including bioproduction of APIs, for example novel anti-infectives, as well as engineering microbial biocatalysts for chemical and fuel production.

About Doris de Guzman

Will Green Chemistry save the world or is it hype? Doris de Guzman examines alternative processing, new technology, R&D and other sustainability initiatives aimed at preventing pollution; replacing ingredients; and using renewable feedstocks in Green Chemistry. She has been covering the oleochemicals market for 15 years and spread her beat to inorganics, biofuels and green chemistry.

Discussion

No comments yet.

Your thoughts?

Confirm if you are currently a subscriber to Tecnon OrbiChem's Bio-Materials newsletter. If not, please contact doris@greenchemicalsblog.com.

TECNON ORBICHEM BIO-MATERIALS SERVICE



TECNON ORBICHEM IS ATTENDING THESE EVENTS

Follow me on Twitter

%d bloggers like this: